✦ LIBER ✦

Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer’s disease

✍ Scribed by Herholz, Karl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of CSF biomarkers in Alzheimer’s dis

✍ K. Blennow; H. Zetterberg 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 57 KB

Topographical Markers of Alzheimer's Dis

✍ Jicha, Gregory 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Use of an fdg-pet-derived hypometabolic

✍ Napatkamon Ayutyanont; Kewei Chen; Auttawut Roontiva; Adam Fleisher; Jessica Lan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Use of an FDG-PET derived hypometabolic

✍ Ayutyanont, Napatkamon; Chen, Kewei; Roontiva, Auttawut; Fleisher, Adam; Langbau 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Neuroimaging biomarkers for clinical tri

✍ Dickerson, Bradford C. ;Sperling, Reisa A. 📂 Article 📅 2005 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 273 KB

Clinical use of cerebrospinal fluid biom

✍ Zetterberg, Henrik; Lunn, Michael P; Herukka, Sanna-Kaisa 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 486 KB